In the Spanish version of the Winter article "Treatment Strategies and Risk Stratification in Acute Coronary Syndrome: How Do We Identify Patients Who Would Benefit From Early Invasive Treatment?", published in the August issue of Revista Española de Cardiología (Rev Esp Cardiol. 2010;63:888-9) on page 889, left column, fourth line from the bottom, "HR = 0,09" should read "HR = 0,9".
This error was corrected in the Spanish and English (ahead of print) electronic versions of the article on September 10, 2010.
In the article by Pérez de Isla et al, "Summary of the Clinical Studies Reported in the Annual Scientific Sessions of the American College of Cardiology (Atlanta, GA. USA, March 14-16, 2010)", published in the July issue of the Revista Española de Cardiología (Rev Esp Cardiol. 2010;63:695-707), the following errors were found:
On pages 695 and 698, the FIR trial was described as a study "in patients with ST elevation acute coronary syndrome"; however, this should read "in patients with non-ST elevation acute coronary syndrome".
On page 696, the section entitled "ACCORD lipid study" ends with the phrase "with a potential benefit for patients with a high baseline triglyceride level and a low level of high-density lipoprotein cholesterol (P=.057 for interaction)", but should read "with a potential benefit for patients with a high baseline triglyceride level and a low baseline level of high-density lipoprotein cholesterol (P=.057 for interaction)."
On page 704, the Section "DES-LATE study" states that "in the dual-therapy group, compared to the aspirin group, there was a significant increase in the composite risk of myocardial infarction", but should state "there was a nonsignificant increase".
This error was corrected in the Spanish and English (ahead of print) electronic versions of the article on September 10, 2010.